INFI News and Press, Infinity Pharmaceuticals Inc. From 07/05/23

Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology macrophage reprogramming drug candidate, announced today that leading independent proxy advisor Institutional S...

Event Available at 8:00 a.m. Eastern Time on June 19, 2023 MEI Pharma, Inc. (Nasdaq: MEIP) (“MEI”), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, and Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a clinic...

2023-06-01 08:47:48 ET MEI Pharma's ( NASDAQ: MEIP ) board has rejected an unsolicited offer from a group wanting to take the company private. The board said that the bid "significantly undervalues the Company, is not superior to the proposed transaction with Infinity Phar...

VANCOUVER, BC / ACCESSWIRE / May 24, 2023 / Infinitum Copper Corp. (TSXV:INFI)(OTCQB:INUMF) ("Infinitum" or the "Company") is pleased to announce the start of drilling at its flagship 6,450 hectare La Adelita property (the "Property") located in Sonora, Mexico. The program, consisting of 15 diam...

VANCOUVER, BC / ACCESSWIRE / May 2, 2023 / Infinitum Copper Corp. (TSXV:INFI)(OTCQB:INUMF) ("Infinitum" or the "Company") is pleased to report results from the last six of twelve diamond drill holes at Infinitum's flagship project, La Adelita in Sonora, Mexico. Drill hole AD-22-0028 returned 4...

VANCOUVER, BC / ACCESSWIRE / April 28, 2023 / Infinitum Copper Corp. (TSXV:INFI)(OTCQB:INUMF) (" Infinitum Copper " or the " Company ") announces that it has closed the first tranche of its previously announced non-brokered private placement financing. The private placement tranche was completed...

VANCOUVER, BC / ACCESSWIRE / APRIL 24, 2023 / Infinitum Copper Corp. (TSXV:INFI)(OTCQB:INUMF) (" Infinitum " or the " Company ") is pleased to announce the successful closing of the first tranche of the C$1,500,000 private placement announced March 15 th , 2023. Tranche 1 comprises a total of 21...

NEW YORK, NY / ACCESSWIRE / April 19, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Partners Bancorp (NASDAQ:PTRS)'s ...

NEW YORK, NY / ACCESSWIRE / April 19, 2023 / New York, New York-Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cvent Holding ...

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced upcoming presentations inc...